101 related articles for article (PubMed ID: 20104324)
1. In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease.
Green DE; Bowen ML; Scott LE; Storr T; Merkel M; Böhmerle K; Thompson KH; Patrick BO; Schugar HJ; Orvig C
Dalton Trans; 2010 Feb; 39(6):1604-15. PubMed ID: 20104324
[TBL] [Abstract][Full Text] [Related]
2. Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease.
Scott LE; Page BD; Patrick BO; Orvig C
Dalton Trans; 2008 Dec; (45):6364-7. PubMed ID: 19002321
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy.
Storr T; Merkel M; Song-Zhao GX; Scott LE; Green DE; Bowen ML; Thompson KH; Patrick BO; Schugar HJ; Orvig C
J Am Chem Soc; 2007 Jun; 129(23):7453-63. PubMed ID: 17511455
[TBL] [Abstract][Full Text] [Related]
4. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
5. Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.
Fernández-Bachiller MI; Pérez C; González-Muñoz GC; Conde S; López MG; Villarroya M; García AG; Rodríguez-Franco MI
J Med Chem; 2010 Jul; 53(13):4927-37. PubMed ID: 20545360
[TBL] [Abstract][Full Text] [Related]
6. Soluble amyloid beta1-28-copper(I)/copper(II)/Iron(II) complexes are potent antioxidants in cell-free systems.
Baruch-Suchodolsky R; Fischer B
Biochemistry; 2008 Jul; 47(30):7796-806. PubMed ID: 18598056
[TBL] [Abstract][Full Text] [Related]
7. Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy.
Storr T; Scott LE; Bowen ML; Green DE; Thompson KH; Schugar HJ; Orvig C
Dalton Trans; 2009 Apr; (16):3034-43. PubMed ID: 19352532
[TBL] [Abstract][Full Text] [Related]
8. Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems.
Baruch-Suchodolsky R; Fischer B
Biochemistry; 2009 May; 48(20):4354-70. PubMed ID: 19320465
[TBL] [Abstract][Full Text] [Related]
9. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
Tõugu V; Karafin A; Palumaa P
J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and cytotoxicity studies of Cu(II), Zn(II), and Fe(III) complexes of N-derivatized 3-hydroxy-4-pyridiones.
Telpoukhovskaia MA; Rodríguez-Rodríguez C; Scott LE; Page BD; Patrick BO; Orvig C
J Inorg Biochem; 2014 Mar; 132():59-66. PubMed ID: 24393377
[TBL] [Abstract][Full Text] [Related]
11. Examination of novel zinc-binding groups for use in matrix metalloproteinase inhibitors.
Puerta DT; Cohen SM
Inorg Chem; 2003 Jun; 42(11):3423-30. PubMed ID: 12767177
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of di-phenyl-tin(IV)-salicyliden-ortho-aminophenols: analysis of in vitro antitumor/antioxidant activities and molecular structures.
Beltrán HI; Damian-Zea C; Hernández-Ortega S; Nieto-Camacho A; Ramírez-Apan MT
J Inorg Biochem; 2007 Jul; 101(7):1070-85. PubMed ID: 17555822
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of new spiroindolinones incorporating a benzothiazole moiety as antioxidant agents.
Karali N; Güzel O; Ozsoy N; Ozbey S; Salman A
Eur J Med Chem; 2010 Mar; 45(3):1068-77. PubMed ID: 20045221
[TBL] [Abstract][Full Text] [Related]
14. Structural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ions.
Kong GK; Adams JJ; Harris HH; Boas JF; Curtain CC; Galatis D; Masters CL; Barnham KJ; McKinstry WJ; Cappai R; Parker MW
J Mol Biol; 2007 Mar; 367(1):148-61. PubMed ID: 17239395
[TBL] [Abstract][Full Text] [Related]
15. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
Ha C; Ryu J; Park CB
Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
[TBL] [Abstract][Full Text] [Related]
16. Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties.
Fernández-Bachiller MI; Pérez C; Campillo NE; Páez JA; González-Muñoz GC; Usán P; García-Palomero E; López MG; Villarroya M; García AG; Martínez A; Rodríguez-Franco MI
ChemMedChem; 2009 May; 4(5):828-41. PubMed ID: 19308922
[TBL] [Abstract][Full Text] [Related]
17. Preparation and study of new poly-8-hydroxyquinoline chelators for an anti-Alzheimer strategy.
Deraeve C; Boldron C; Maraval A; Mazarguil H; Gornitzka H; Vendier L; Pitié M; Meunier B
Chemistry; 2008; 14(2):682-96. PubMed ID: 17969218
[TBL] [Abstract][Full Text] [Related]
18. NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.
Hou L; Zagorski MG
J Am Chem Soc; 2006 Jul; 128(29):9260-1. PubMed ID: 16848423
[TBL] [Abstract][Full Text] [Related]
19. Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease.
Cherny RA; Barnham KJ; Lynch T; Volitakis I; Li QX; McLean CA; Multhaup G; Beyreuther K; Tanzi RE; Masters CL; Bush AI
J Struct Biol; 2000 Jun; 130(2-3):209-16. PubMed ID: 10940226
[TBL] [Abstract][Full Text] [Related]
20. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
Mancino AM; Hindo SS; Kochi A; Lim MH
Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
